{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:48:48Z","timestamp":1764510528755,"version":"3.46.0"},"reference-count":36,"publisher":"Practical Medicine Publishing House","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Aim.\u00a0To evaluate types of response to azacitidine associated with improvement of overall survival (OS) rates of patients with acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS).\r\nMethods.\u00a0A retrospective analyses of medical records of 14 AML patients and 13 MDS patients at the age of 39 to 84 treated with azacitidine at a dose of 75 mg\/m2\u00a0subcutaneously for 7 subsequent days every 28 days was performed. The therapy effectiveness was evaluated according to modified 2006 IWG criteria. The OS was calculated beginning with the date of initiation of the azacitidine therapy.\r\nResults.\u00a0From 2 to 25 azacitidine cycles was performed. Complete remission (CR) was achieved in 6 patients (22.2\u00a0%) including 4 AML and 2 MDS patients. Bone marrow remission (mCR) was diagnosed in 1 MDS patient (3.7\u00a0%). Hematological improvement was obtained in 11 patients (40.7\u00a0%) including 5 AML and 6 MDS patients. The overall response was 66.7\u00a0% (18 to 27 patients). There was no correlation between the therapy effectiveness and patients\u2019 age, disease type, duration of the previous period, baseline hemoglobin, leukocytes, and platelets levels, and dependence on transfusions of erythrocyte suspension and thromboconcentrate. The therapy was considered ineffective in 9 patients (33.3\u00a0%). Stabilization with retained requirements of blood component transfusion was observed in 4 AML and 3 MDS patients. 2 patients presented gradual increase of the blast cell count in the bone marrow. The follow-up period was 2\u201329 months. The median OS of all patients was 11.5 months. The median OS of patients with CR, mCR and hematological improvement was significantly greater than that in the group of patients with stable disease and progression: 15.9 versus 7.4 months, respectively (p\u00a0=\u00a00,010).\r\nConclusion.\u00a0Reduction of transfusion requirement and\/or stable improvement of peripheral blood levels due to azacitidine administration are associated with improved OS rates of AML and MDS patients.<\/jats:p>","DOI":"10.21320\/2500-2139-2015-8-4-413-419","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:21:14Z","timestamp":1460622074000},"page":"413-419","source":"Crossref","is-referenced-by-count":2,"title":["Hematological Improvement is a Favorable Response to Azacitidine in Patients with Acute Myeloid Leukemias and Myelodysplastic Syndromes","\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0443\u043b\u0443\u0447\u0448\u0435\u043d\u0438\u0435 \u2014 \u0432\u0430\u0440\u0438\u0430\u043d\u0442 \u0431\u043b\u0430\u0433\u043e\u043f\u0440\u0438\u044f\u0442\u043d\u043e\u0433\u043e \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u043e\u043f\u0443\u0445\u043e\u043b\u0435\u0432\u043e\u0433\u043e \u043e\u0442\u0432\u0435\u0442\u0430 \u043d\u0430 \u043b\u0435\u0447\u0435\u043d\u0438\u0435 \u0430\u0437\u0430\u0446\u0438\u0442\u0438\u0434\u0438\u043d\u043e\u043c \u043f\u0440\u0438 \u043e\u0441\u0442\u0440\u044b\u0445 \u043c\u0438\u0435\u043b\u043e\u0438\u0434\u043d\u044b\u0445 \u043b\u0435\u0439\u043a\u043e\u0437\u0430\u0445 \u0438 \u043c\u0438\u0435\u043b\u043e\u0434\u0438\u0441\u043f\u043b\u0430\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u0430\u0445"],"prefix":"10.21320","volume":"8","author":[{"given":"Ivan Ivanovich","family":"Kostroma","sequence":"first","affiliation":[{"name":"Russian Scientific Research Institute of Hematology and Transfusiology under the Federal Medico-Biological Agency, 16 2-ya Sovetskaya str., Saint Petersburg, Russian Federation, 191024"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u0443\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u0424\u041c\u0411\u0410 \u0420\u0424, 2-\u044f \u0421\u043e\u0432\u0435\u0442\u0441\u043a\u0430\u044f \u0443\u043b., \u0434. 16, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 191024"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Gritsaev","sequence":"additional","affiliation":[{"name":"Russian Scientific Research Institute of Hematology and Transfusiology under the Federal Medico-Biological Agency, 16 2-ya Sovetskaya str., Saint Petersburg, Russian Federation, 191024"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u0443\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u0424\u041c\u0411\u0410 \u0420\u0424, 2-\u044f \u0421\u043e\u0432\u0435\u0442\u0441\u043a\u0430\u044f \u0443\u043b., \u0434. 16, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 191024"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Karyagina","sequence":"additional","affiliation":[{"name":"Municipal Hospital No. 15, 4 Avangardnaya str., Saint Petersburg, Russian Federation, 198205"},{"name":"\u0413\u0411\u0423\u0417 \u00ab\u0413\u043e\u0440\u043e\u0434\u0441\u043a\u0430\u044f \u0431\u043e\u043b\u044c\u043d\u0438\u0446\u0430 \u2116 15\u00bb, \u0443\u043b. \u0410\u0432\u0430\u043d\u0433\u0430\u0440\u0434\u043d\u0430\u044f, \u0434. 4, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f,198205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Nizamutdinova","sequence":"additional","affiliation":[{"name":"Alexandrovskaya Municipal Hospital No. 17, 4 pr-t Solidarnosti, Saint Petersburg, Russian Federation, 193312"},{"name":"\u0410\u043b\u0435\u043a\u0441\u0430\u043d\u0434\u0440\u043e\u0432\u0441\u043a\u0430\u044f \u0433\u043e\u0440\u043e\u0434\u0441\u043a\u0430\u044f \u0431\u043e\u043b\u044c\u043d\u0438\u0446\u0430 \u2116 17, \u043f\u0440-\u0442 \u0421\u043e\u043b\u0438\u0434\u0430\u0440\u043d\u043e\u0441\u0442\u0438, \u0434. 4, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 193312"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. S.","family":"Martynkevich","sequence":"additional","affiliation":[{"name":"Russian Scientific Research Institute of Hematology and Transfusiology under the Federal Medico-Biological Agency, 16 2-ya Sovetskaya str., Saint Petersburg, Russian Federation, 191024"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u0443\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u0424\u041c\u0411\u0410 \u0420\u0424, 2-\u044f \u0421\u043e\u0432\u0435\u0442\u0441\u043a\u0430\u044f \u0443\u043b., \u0434. 16, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 191024"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Abdulkadyrov","sequence":"additional","affiliation":[{"name":"Russian Scientific Research Institute of Hematology and Transfusiology under the Federal Medico-Biological Agency, 16 2-ya Sovetskaya str., Saint Petersburg, Russian Federation, 191024"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u0443\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0438\u00bb \u0424\u041c\u0411\u0410 \u0420\u0424, 2-\u044f \u0421\u043e\u0432\u0435\u0442\u0441\u043a\u0430\u044f \u0443\u043b., \u0434. 16, \u0421\u0430\u043d\u043a\u0442-\u041f\u0435\u0442\u0435\u0440\u0431\u0443\u0440\u0433, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 191024"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"20145","unstructured":"\u0413\u0440\u0438\u0446\u0430\u0435\u0432 \u0421.\u0412. \u041c\u0438\u0435\u043b\u043e\u0434\u0438\u0441\u043f\u043b\u0430\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u044b. \u0412 \u043a\u043d.: \u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0435 \u0440\u0443\u043a\u043e\u0432\u043e\u0434\u0441\u0442\u0432\u043e \u043f\u043e \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438. \u041f\u043e\u0434 \u0440\u0435\u0434. \u041e.\u0410. \u0420\u0443\u043a\u0430\u0432\u0438\u0446\u0438\u043d\u0430. \u041c: \u0413\u042d\u041e\u0422\u0410\u0420-\u041c\u0435\u0434\u0438\u0430, 2015. \u0421. 300\u201333."},{"key":"20146","unstructured":"[Gritsaev SV. Myelodysplastic syndromes. In: Rukavitsin OA, ed. Gematologiya. Natsional\u2019noe rukovodstvo po gematologii. (Hematology. National guidelines in hematology.) Moscow: GEOTAR-Media Publ.; 2015. p. 300\u201333. (In Russ)]"},{"key":"20147","unstructured":"\u0413\u0440\u0438\u0446\u0430\u0435\u0432 \u0421.\u0412., \u041c\u0430\u0440\u0442\u044b\u043d\u043a\u0435\u0432\u0438\u0447 \u0418.\u0421., \u0410\u0431\u0434\u0443\u043b\u043a\u0430\u0434\u044b\u0440\u043e\u0432 \u041a.\u041c. \u0438 \u0434\u0440. \u0412\u043e\u0437\u0440\u0430\u0441\u0442\u043d\u044b\u0435 \u043e\u0441\u043e\u0431\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u043a\u0430\u0440\u0438\u043e\u0442\u0438\u043f\u0430 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u043e\u0441\u0442\u0440\u044b\u043c \u043c\u0438\u0435\u043b\u043e\u0438\u0434\u043d\u044b\u043c \u043b\u0435\u0439\u043a\u043e\u0437\u043e\u043c. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2011;1:51\u20135."},{"key":"20148","unstructured":"[Gritsaev SV, Martynkevich IS, Abdulkadyrov KM, et al. Age-related features of karyotype of patients with acute myeloid leukemias. Terapevticheskii arkhiv. 2011;1:51\u20135. (In Russ)]"},{"key":"20149","unstructured":"\u0413\u0440\u0438\u0446\u0430\u0435\u0432 \u0421.\u0412., \u041c\u0430\u0440\u0442\u044b\u043d\u043a\u0435\u0432\u0438\u0447 \u0418.\u0421., \u0410\u0431\u0434\u0443\u043b\u043a\u0430\u0434\u044b\u0440\u043e\u0432 \u041a.\u041c. \u0438 \u0434\u0440. \u041a\u043e\u043c\u043f\u043b\u0435\u043a\u0441\u043d\u044b\u0439 \u043a\u0430\u0440\u0438\u043e\u0442\u0438\u043f \u2014 \u043c\u0430\u0440\u043a\u0435\u0440 \u043a\u0440\u0430\u0439\u043d\u0435 \u043d\u0435\u0431\u043b\u0430\u0433\u043e\u043f\u0440\u0438\u044f\u0442\u043d\u043e\u0433\u043e \u043f\u0440\u043e\u0433\u043d\u043e\u0437\u0430 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u043e\u0441\u0442\u0440\u044b\u043c\u0438 \u043c\u0438\u0435\u043b\u043e\u0438\u0434\u043d\u044b\u043c\u0438 \u043b\u0435\u0439\u043a\u043e\u0437\u0430\u043c\u0438 \u0438 \u0440\u0430\u0437\u0432\u0435\u0440\u043d\u0443\u0442\u044b\u043c\u0438 \u0432\u0430\u0440\u0438\u0430\u043d\u0442\u0430\u043c\u0438 \u043c\u0438\u0435\u043b\u043e\u0434\u0438\u0441\u043f\u043b\u0430\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u0430 \u0441\u0442\u0430\u0440\u0448\u0435 70 \u043b\u0435\u0442 \u0441 \u0432\u044b\u0441\u043e\u043a\u0438\u043c \u0438\u043d\u0434\u0435\u043a\u0441\u043e\u043c \u043a\u043e\u043c\u043e\u0440\u0431\u0438\u0434\u043d\u043e\u0441\u0442\u0438. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2012;7:16\u201321."},{"key":"20150","unstructured":"[Gritsaev SV, Martynkevich IS, Abdulkadyrov KM, et al. Complex karyotype is a marker for extremely unfavorable prognosis in patients with acute myeloid leukemia and marked myelodysplastic syndrome in patients over 70 years old with high co-morbidity index. Terapevticheskii arkhiv. 2012;7:16\u201321. (In Russ)]"},{"key":"20151","unstructured":"\u0413\u0440\u0438\u0446\u0430\u0435\u0432 \u0421.\u0412., \u041c\u0430\u0440\u0442\u044b\u043d\u043a\u0435\u0432\u0438\u0447 \u0418.\u0421., \u0417\u0430\u043f\u0440\u0435\u0435\u0432\u0430 \u0418.\u041c. \u0438 \u0434\u0440. \u042d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c \u043f\u0435\u0440\u0432\u043e\u0433\u043e \u0438 \u043f\u043e\u0432\u0442\u043e\u0440\u043d\u043e\u0433\u043e \u043a\u0443\u0440\u0441\u043e\u0432 \u0438\u043d\u0434\u0443\u043a\u0446\u0438\u043e\u043d\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 de novo \u043e\u0441\u0442\u0440\u044b\u043c \u043c\u0438\u0435\u043b\u043e\u0438\u0434\u043d\u044b\u043c \u043b\u0435\u0439\u043a\u043e\u0437\u043e\u043c. \u0411\u044e\u043b\u043b\u0435\u0442\u0435\u043d\u044c \u0421\u041e \u0410\u041c\u041d 2013;33(1):67\u201375."},{"key":"20152","unstructured":"[Gritsaev SV, Martynkevich IS, Zapreeva IM, et al. Efficacy of the first and repeated courses of induced therapy of patients with de novo acute myeloid leukemia. Byulleten\u2019 SO AMN. 2013;33(1):67\u201375. (In Russ)]"},{"key":"20153","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1302"},{"key":"20154","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.1820"},{"key":"20155","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22496"},{"key":"20156","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"20157","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8329"},{"key":"20158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436055"},{"key":"20159","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.400"},{"key":"20160","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.134"},{"key":"20161","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.4222"},{"key":"20162","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4149"},{"key":"20163","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"20164","unstructured":"\u0413\u0440\u0438\u0446\u0430\u0435\u0432 \u0421.\u0412., \u041c\u0430\u0440\u0442\u044b\u043d\u043a\u0435\u0432\u0438\u0447 \u0418.\u0421., \u041a\u043e\u0441\u0442\u0440\u043e\u043c\u0430 \u0418.\u0418. \u0410\u0437\u0430\u0446\u0438\u0442\u0438\u0434\u0438\u043d \u043f\u0440\u0438 \u043e\u0441\u0442\u0440\u043e\u043c \u043c\u0438\u0435\u043b\u043e\u0431\u043b\u0430\u0441\u0442\u043d\u043e\u043c \u043b\u0435\u0439\u043a\u043e\u0437\u0435 \u0438 \u043c\u0438\u0435\u043b\u043e\u0434\u0438\u0441\u043f\u043b\u0430\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u043c \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u0435. \u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u0443\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u044f. 2012;1:23\u20139."},{"key":"20165","unstructured":"[Gritsaev SV, Martynkevich IS, Kostroma II. Azacitidine in acute myeloblast leukemia and myelodysplactic syndrome. Gematologiya i transfuziologiya. 2012;1:23\u20139. (In Russ)]"},{"key":"20166","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-3-10"},{"key":"20167","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010611"},{"key":"20168","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.511"},{"key":"20169","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2126-9"},{"key":"20170","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.12.013"},{"key":"20171","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1799-9"},{"key":"20172","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-582809"},{"key":"20173","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.4.234"},{"key":"20174","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.834532"},{"key":"20175","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.03.012"},{"key":"20176","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.04.015"},{"key":"20177","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1904.1904"},{"key":"20178","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23808"},{"key":"20179","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12079"},{"key":"20180","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3273.3273"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/567\/525","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/567\/525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:20:07Z","timestamp":1764501607000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2015-8-4-413-419","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}